DAPAGLIFLOZIN
- Product NDC
- 50090-7056
- 11-digit product format
- 500907056
- Labeler code
- 50090
- Product ID
- 50090-7056_45a2ec6f-a7e4-42bf-8890-51332f8cfbde
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DAPAGLIFLOZIN
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- NDA202293
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2024-01-03
- Substance
- DAPAGLIFLOZIN PROPANEDIOL
- Active strength
- 5 mg/1
- Pharmacologic classes
- Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- DAPAGLIFLOZIN
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DAPAGLIFLOZIN PROPANEDIOL | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 887K2391VH |
| Rxcui | 1488574 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-7056-0 | DAPAGLIFLOZIN | 30 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 30 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-7056 | DAPAGLIFLOZIN TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 4 | Current NDC, 1 package rows | 20240629_82cdd5ad-df2b-4bdd-a3a6-a059040100b4.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-7056-0 | 50090705600 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-7056-0) | 2024-01-16 | No | No | Current |